Anil Potti, in a Duke commercial advertising the trial Shoffner joined.Joyce Shoffner would never have predicted that Duke University, an institution she revered and at one time worked for, would put her in a breast cancer clinical trial testing a fraudulent technology.
A year ago, Fox Chase Cancer Center lost money: $17 million. In 2015, the losses have stopped, and an $8 million operating profit is projected.
NCI surgeon Richard Sherry tried unsuccessfully to refocus FDA's approval question.
The breast cancer screening recommendations proposed by the U.S. Preventive Services Task Force earlier this week are basically unchanged from the 2009 version.
Douglas Lowy became the NCI acting director April 1. On April 16, Lowy spoke with Paul Goldberg, editor and publisher of The Cancer Letter.
MD Anderson Cancer Center President Ronald DePinho's administration acted in disregard of academic standards and the institution's internal faculty appointment policy, according to a 23-page final report published April 8 by the American Association of University Professors.
Over the first two days in April, massive leadership changes occurred at top institutions in cancer research:
"All Pull; No Push"—Varmus Describes his Reasons for Leaving in Farewell Town Hall
There will be no more faculty surveys at MD Anderson, UT System Chancellor William McRaven pledged to the institution's faculty in a closed-door meeting March 18.
